ADMA Biologics Inc (ADMA)
6.27
+0.07
(+1.13%)
USD |
NASDAQ |
Apr 19, 16:00
6.29
+0.02
(+0.32%)
After-Hours: 17:43
ADMA Biologics Cash from Financing (TTM): -38.99M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -38.99M |
September 30, 2023 | 62.75M |
June 30, 2023 | 61.49M |
March 31, 2023 | 60.93M |
December 31, 2022 | 108.85M |
September 30, 2022 | 99.93M |
June 30, 2022 | 108.97M |
March 31, 2022 | 126.47M |
December 31, 2021 | 121.05M |
September 30, 2021 | 99.29M |
June 30, 2021 | 101.72M |
March 31, 2021 | 84.54M |
December 31, 2020 | 143.90M |
September 30, 2020 | 111.83M |
June 30, 2020 | 101.19M |
March 31, 2020 | 177.03M |
December 31, 2019 | 80.00M |
September 30, 2019 | 80.01M |
June 30, 2019 | 80.00M |
March 31, 2019 | 47.10M |
December 31, 2018 | 42.92M |
September 30, 2018 | 93.30M |
June 30, 2018 | 91.65M |
March 31, 2018 | 61.86M |
December 31, 2017 | 60.75M |
Date | Value |
---|---|
September 30, 2017 | 10.37M |
June 30, 2017 | 11.84M |
March 31, 2017 | 15.73M |
December 31, 2016 | 16.84M |
September 30, 2016 | 16.78M |
June 30, 2016 | 16.85M |
March 31, 2016 | -0.0614M |
December 31, 2015 | 10.40M |
September 30, 2015 | 15.50M |
June 30, 2015 | 15.58M |
March 31, 2015 | 15.47M |
December 31, 2014 | 9.795M |
September 30, 2014 | 31.43M |
June 30, 2014 | 31.44M |
March 31, 2014 | 31.50M |
December 31, 2013 | 27.63M |
September 30, 2013 | 4.621M |
June 30, 2013 | 4.613M |
March 31, 2013 | 4.246M |
December 31, 2012 | 19.47M |
September 30, 2012 | 15.83M |
June 30, 2012 | 15.87M |
March 31, 2012 | 16.17M |
December 31, 2011 | 0.0346M |
September 30, 2011 | 0.0281M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-38.99M
Minimum
Dec 2023
177.03M
Maximum
Mar 2020
93.21M
Average
99.93M
Median
Sep 2022
Cash from Financing (TTM) Benchmarks
Vanda Pharmaceuticals Inc | -- |
Puma Biotechnology Inc | 0.00 |
ANI Pharmaceuticals Inc | 67.44M |
Bristol-Myers Squibb Co | -9.416B |
Ligand Pharmaceuticals Inc | -59.95M |